K-V Investor Group Bumps Up Ch. 11 Offer To $275M

Law360, New York (May 29, 2013, 7:26 PM EDT) -- An investor group that has proposed a Chapter 11 plan that would allow it to take over K-V Pharmaceutical Co. upped its proposal to $275 million on Wednesday in New York bankruptcy court, once again raising the stakes for a group of senior bondholders who first sought to take over the company.

The group, which includes Greywolf Capital Partners II LP, Capital Ventures International, Deutsche Bank Securities Inc. and Kingdon Capital Management LLC, recently wooed K-V with an alternative plan that offered more than five times...
To view the full article, register now.